Skip to content
2000
Volume 5, Issue 2
  • ISSN: 1871-5230
  • E-ISSN: 1875-614X

Abstract

PLA2 is an important signaling enzyme that generates multiple downstream effectors, such as arachidonic acid and PAF, which are key mediators of inflammation as well as other pathophysiological conditions. Inhibition of PLA2 is potentially an effective therapy for several inflammatory diseases. In this review, we discuss the various classes of synthetic inhibitors of Group IVA and Group VIA phospholipase A2.

Loading

Article metrics loading...

/content/journals/aiaamc/10.2174/187152306776872451
2006-05-01
2025-05-21
Loading full text...

Full text loading...

/content/journals/aiaamc/10.2174/187152306776872451
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test